Pfizer says US appeals court reverses earlier ruling upholding Norvasc patent |
|
|
|
Published
:
Thu, 22 Mar 2007 19:32 |
LONDON (AFX) - Pharmaceutical group Pfizer Inc said a US appeals court has reversed a lower ruling that upheld the company's US patent covering amlodipine besylate, the active ingredient in the popular high blood pressure medication Norvasc.Pfizer said it is reviewing the decision and is considering all its options, including seeking a reconsideration.newsdesk@afxnews.comwjCOPYRIGHTCopyright AFX News Limited 2007. All rights reserved.The copying, republication or redistribution of AFX News Content, including by framing or similar means, is expressly prohibited without the prior written consent of AFX News.AFX News and AFX Financial News Logo are registered trademarks of AFX News Limited
|
|
|
|